Literature DB >> 9595438

Subtype-specific endothelin-A and endothelin-B receptor desensitization correlates with differential receptor phosphorylation.

H Cramer1, W Müller-Esterl, C Schroeder.   

Abstract

In the rat cardiovascular system endothelin-1 (ET-1) elicits prolonged physiologic responses mediated by the ETA receptor, whereas the effects mediated by the ETB receptor are transient. The molecular mechanisms for the subtype-specific responses are not yet clear. However, post-translational modifications such as phosphorylation and palmitoylation may play an important role. In Sf9 cells overexpressing the human ETA and ETB receptors, both subtypes are palmitoylated. However, only the ETB but not the ETA receptor is phosphorylated in a ligand-dependent manner. Because phosphorylation is believed to play an important role in ligand-dependent receptor inactivation, we analyzed whether the differential phosphorylation of the ETA and ETB receptors reflects a differential mechanism of receptor inactivation. Using a modified inositol phosphate accumulation assay, we analyzed CHO cells that expressed the ETA or ETB receptor. The ETB receptor was deactivated almost completely within 5 min after agonist stimulation, whereas stimulation of the ETA receptor resulted in sustained activation, i.e., > 90% of the initial activity was maintained after 5 min of ligand stimulation and > 30% after 20 min. A strong correlation was observed between the time course of ETA receptor inactivation and ETA receptor internalization. The endogenous ETA receptor in Rat-1 cells produced a prolonged stimulation of phospholipase C similar to that seen in CHO cells. Therefore, the sustained signaling activity of the ETA receptor is not a property only of recombinant cell lines. Together, our data suggest rapid ETB receptor inactivation due to phosphorylation and delayed ETA receptor inactivation by internalization. These mechanisms adequately reflect the differential response patterns of the ET receptors under physiologic conditions.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9595438     DOI: 10.1097/00005344-199800001-00057

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  3 in total

1.  Role of GRK4 in the regulation of the renal ETB receptor in hypertension.

Authors:  Yang Yang; Meixiang Li; Xue Zou; Caiyu Chen; Shuo Zheng; Chunjiang Fu; Ken Chen; Pedro A Jose; Cong Lan; Yukai Liu
Journal:  FASEB J       Date:  2020-07-20       Impact factor: 5.191

2.  Increased endothelin-1 vasoconstriction in mesenteric resistance arteries after superior mesenteric ischaemia-reperfusion.

Authors:  S Martínez-Revelles; L Caracuel; A Márquez-Martín; Ap Dantas; E Oliver; P D'Ocon; E Vila
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

3.  Endothelin-1 promotes hypertrophic remodelling of cardiac myocytes by activating sustained signalling and transcription downstream of endothelin type A receptors.

Authors:  Caroline R Archer; Emma L Robinson; Faye M Drawnel; H Llewelyn Roderick
Journal:  Cell Signal       Date:  2017-04-13       Impact factor: 4.315

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.